Posted on

SARS-CoV-2 Receptor Binding Domain Omicron Mutant 6VXX

Featured Image

The severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) variant Omicron spread more rapid than the other variants of SARS-CoV-2 virus. Simulation results show that the Omicron Variant have stronger binding to ACE2 than other variants. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain Omicron Mutant 6VXX helps research…

Read more

Posted on

SARS-CoV-2 Receptor Binding Domain Delta Plus Mutant 6VXX

featured image

The SARS-CoV2 Delta Plus variant was first reported in India. This new variant, was shown to carry mutation K417N on its receptor-binding domain (RBD), a mutation previously reported in the Beta variant. Experts believe it contributes to immune evasion in SARS-CoV-2 and synergistic with mutation L452R, another mutation known to also contribute to immune evasion.…

Read more

Posted on

SARS-CoV-2 Receptor Binding Domain ACE2 Complex 6M17

Featured Image

The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain (RBD) ACE2 Receptor Complex 6M17 to help research scientists and the general public better understand how SARS-CoV-2 binds ACE2 Receptors. (more…)

Read more

Posted on

SARS-CoV-2 Receptor Binding Domain Antibody Complex 7KS9

Featured Image

The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain Neutralizing Antibody Complex 7KS9 to help research scientists and the general public better understand how to neutralize Spike Glycoprotein. (more…)

Read more

Posted on

SARS-CoV-2 Receptor Binding Domain 6VXX

Featured Image

The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain 6VXX to help research scientists and the general public better understand the binding properties of the Spike Glycoprotein and how it compares to other Coronavirus Spike Glycoproteins.…

Read more

Posted on

SARS-CoV-2 Spike Glycoprotein Antibody Complex 6VXX-7KS9

The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Spike Glycoprotein 7KS9 to help scientists better visualize…

Read more

Posted on

SARS-CoV-2 Spike Glycoprotein Postfusion 6XRA

Featured Image

The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Spike Glycoprotein Postfusion 6XRA to help scientists better…

Read more

Posted on

SARS-CoV1 Receptor Binding Domain 5X58

Featured Image

The SARS-CoV1 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV1 Receptor Binding Domain 5X58 to help research scientists and the general public better understand the binding properties of the Spike Glycoprotein and how it compares to other Coronavirus Spike Glycoproteins.…

Read more